References
- Ministry of Health, Labour, and Welfare (MHLW) Study Group. Manual for the diagnosis and treatment of rheumatoid arthritis (revised edition) - Diagnostic manuals and evidence-based guide-lines on diagnosis and treatment (in Japanese). Tokyo: Japan Rheu-matism Foundation; 2004.
- Nishimura K, Uchida S, Watanabe F. Long-term results of bucilla-mine in rheumatoid arthritis - Five-year results and prediction of responses at early stages of administration (in Japanese). Jpn J In-flamm 1993;13:293–9.
- Saito M, Nagasawa T. Comparison of usefulness in the treatment of rheumatoid arthritis among DMARDs by the life table method (in Japanese). J Clin Exp Med 1998;186:139–43.
- Mitsuhashi H, Banpa K. Long-term results of bucillamine in rheu-matoid arthritis (in Japanese). Chin Ftheumatol Relat Res 2001;13:268–74.
- Weinblatt ME, Maier AL, Fraser PA, Coblyn JS. Longterm pro-spective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy. J Ftheumatol 1998;25:238–42.
- American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the Management of Rheuma-toid Arthritis 2002 Update. Arthritis Rheum 2002;46:328–46.
- Wyeth KK. Information for proper use of Ftheumatrex, vol. 11 (in Japanese). 2006.
- Santen Pharmaceutical Co. Ltd. Summary of adverse reactions to Ftimatil (in Japanese). 2006.